Literature DB >> 1544114

In vivo selection of a highly metastatic cell line from a human pancreatic carcinoma in the nude mouse.

M P Vezeridis1, G N Tzanakakis, P A Meitner, C M Doremus, L M Tibbetts, P Calabresi.   

Abstract

A cell line with high metastatic capacity to the liver was established by sequential passages of a human pancreatic cancer cell line through the nude mouse liver. A subline, L3.5, established after five passages of the fast-growing variant (FG) of the human pancreatic cancer COLO 357 through the nude mouse liver produced extensive hepatic metastases in 100% of experimental animals when injected into the spleen. The incidence of pulmonary metastases decreased from 43% for FG to 9% for L3.5. The L3.5 cell line showed aggressive growth with almost complete replacement of the hepatic parenchyma in one third of the mean time required for the development of macroscopic metastases of FG in the liver after splenic injections of tumor cells. This study indicates that the nude mouse provides a good model for in vivo selection of metastatic cells from human pancreatic cancer. The L3.5 cell line will be valuable in the study of human pancreatic cancer metastasis, particularly in the area of survival and growth of metastatic cells in the microenvironment of the liver.

Entities:  

Mesh:

Year:  1992        PMID: 1544114     DOI: 10.1002/1097-0142(19920415)69:8<2060::aid-cncr2820690810>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

1.  In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.

Authors:  C J Bruns; M T Harbison; H Kuniyasu; I Eue; I J Fidler
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.

Authors:  Ming Quan; Jiujie Cui; Tian Xia; Zhiliang Jia; Dacheng Xie; Daoyan Wei; Suyun Huang; Qian Huang; Shaojiang Zheng; Keping Xie
Journal:  Cancer Res       Date:  2015-10-19       Impact factor: 12.701

3.  The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome.

Authors:  Peter T Yu; Michele Babicky; Dawn Jaquish; Randy French; Karly Marayuma; Evangeline Mose; Sherry Niessen; Heather Hoover; David Shields; David Cheresh; Benjamin F Cravatt; Andrew M Lowy
Journal:  Int J Cancer       Date:  2012-03-08       Impact factor: 7.396

4.  Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth.

Authors:  Megumi Morimoto-Tomita; Yoshimi Ohashi; Azusa Matsubara; Makoto Tsuiji; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

5.  Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.

Authors:  John P Eggers; Paul M Grandgenett; Eric C Collisson; Michelle E Lewallen; Jarrod Tremayne; Pankaj K Singh; Benjamin J Swanson; Judy M Andersen; Thomas C Caffrey; Robin R High; Michel Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2011-08-08       Impact factor: 12.531

6.  FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.

Authors:  Jiujie Cui; Min Shi; Dacheng Xie; Daoyan Wei; Zhiliang Jia; Shaojiang Zheng; Yong Gao; Suyun Huang; Keping Xie
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

7.  A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy.

Authors:  B Wang; Q Shi; J L Abbruzzese; Q Xiong; X Le; K Xie
Journal:  Int J Pancreatol       Date:  2001

8.  TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation.

Authors:  Zhongkui Li; Zhe Chang; Lucia J Chiao; Ya'an Kang; Qianghua Xia; Cihui Zhu; Jason B Fleming; Douglas B Evans; Paul J Chiao
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

9.  The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.

Authors:  Kun Guo; Jiujie Cui; Ming Quan; Dacheng Xie; Zhiliang Jia; Daoyan Wei; Liang Wang; Yong Gao; Qingyong Ma; Keping Xie
Journal:  Clin Cancer Res       Date:  2016-07-22       Impact factor: 12.531

10.  Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.

Authors:  Xiangyu Kong; Lei Li; Zhaoshen Li; Xiangdong Le; Chen Huang; Zhiliang Jia; Jiujie Cui; Suyun Huang; Liwei Wang; Keping Xie
Journal:  Cancer Res       Date:  2013-04-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.